ProShares UltraPro Short Dow30 (NYSEARCA:SDOW – Get Free Report)’s share price gapped up before the market opened on Monday . The stock had previously closed at $44.43, but opened at $46.08. ProShares UltraPro Short Dow30 shares last traded at $45.70, with a volume of 982,808 shares.
ProShares UltraPro Short Dow30 Stock Performance
The firm’s fifty day simple moving average is $47.44 and its 200 day simple moving average is $52.63.
Institutional Trading of ProShares UltraPro Short Dow30
A number of institutional investors have recently made changes to their positions in the business. Walleye Capital LLC acquired a new stake in shares of ProShares UltraPro Short Dow30 in the third quarter valued at about $727,000. Flow Traders U.S. LLC grew its stake in ProShares UltraPro Short Dow30 by 21.0% in the third quarter. Flow Traders U.S. LLC now owns 52,397 shares of the exchange traded fund’s stock valued at $685,000 after purchasing an additional 9,090 shares in the last quarter. XTX Topco Ltd acquired a new position in shares of ProShares UltraPro Short Dow30 during the 3rd quarter worth approximately $137,000. JPMorgan Chase & Co. raised its stake in shares of ProShares UltraPro Short Dow30 by 19.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,280 shares of the exchange traded fund’s stock worth $43,000 after purchasing an additional 543 shares in the last quarter. Finally, Werba Rubin Papier Wealth Management bought a new stake in shares of ProShares UltraPro Short Dow30 during the 4th quarter worth approximately $344,000.
ProShares UltraPro Short Dow30 Company Profile
ProShares UltraPro Short Dow30 (the Fund) seeks daily investment results that correspond to three times (300%) the inverse (opposite) of the daily performance of the Dow Jones Industrial Average (the Index). The Index is a price-weighted index maintained by editors of The Wall Street Journal. The Index includes 30 large-cap, United States stocks, excluding utility and transportation companies.
Recommended Stories
- Five stocks we like better than ProShares UltraPro Short Dow30
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now
- Transportation Stocks Investing
- Big Dividend Hikes: 4 Large-Cap Stocks Increasing Payouts
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Procter & Gamble: A Consumer Staples Titan Built to Win
Receive News & Ratings for ProShares UltraPro Short Dow30 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraPro Short Dow30 and related companies with MarketBeat.com's FREE daily email newsletter.
